Niagen Bioscience taps Evotec for NB4168 preclinical drug studies
Go back to Niagen Bioscience taps Evotec for NB4168 preclinical drug studies| EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) | Delayed: 1.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $16.39 | |||
| Open | $1.94 | 52 Week Low | $13.22 | |||
| Day High | $1.96 | P/E | N/A | |||
| Day Low | $1.92 | EPS | $-1.61 | |||
| Volume | 30,202 | |||||
| (NASDAQ: NAGE) | Delayed: 3.04 +0.02 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.02 | 52 Week High | $ | |||
| Open | $3.01 | 52 Week Low | $ | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $2.96 | EPS | $ | |||
| Volume | 616,794 | |||||

